Renal outcomes in the ONTARGET study — Authors’ reply
Wetzels JF. Lancet. 2008 Dec 13;372(9655):2020; author reply 2020-1
Related Articles:
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
- Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies.
- Proteinuria: Is the ONTARGET renal substudy actually off target?
Recent Comments